InterCure and Cookies Launch Flagship Retail Location in
NEW YORK and TORONTO and HERZLIYA, Israel, June 21, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) ("InterCure" or the...
Source: globenewswire.com
Page 13 - Intercure Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Intercure Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Intercure Ltd Today - Breaking & Trending Today
InterCure and Cookies Launch Flagship Retail Location in Vienna, Austria
NEW YORK and TORONTO and HERZLIYA, Israel, June 21, 2022 (GLOBE NEWSWIRE) — InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (“InterCure” or the…
Source: lfpress.com
InterCure Ltd (NASDAQ:INCR): This Cannabis Stock Could Rise by 125%
InterCure Ltd (NASDAQ:INCR) says it's the leading marijuana company outside of North America. It has reported record 2021 and first-quarter 2022 financial results. As such, INCR stock could be set to soar in value.
Source: profitconfidential.com
InterCure (NASDAQ:INCR) vs. Phibro Animal Health (NASDAQ:PAHC) Head to Head Contrast
Phibro Animal Health (NASDAQ:PAHC – Get Rating) and InterCure (NASDAQ:INCR – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk. Analyst Ratings This is a summary of current ratings […]
Source: etfdailynews.com
InterCure (NASDAQ:INCR) versus Sanofi (NASDAQ:SNY) Head-To-Head Review
InterCure (NASDAQ:INCR – Get Rating) and Sanofi (NASDAQ:SNY – Get Rating) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, institutional ownership, risk and analyst recommendations. Valuation and Earnings This table compares InterCure and Sanofi’s gross revenue, earnings […]
Source: etfdailynews.com